
Protein Dynamic Solutions
PDS offers ProteinMentorTM, a high-tech analytical platform providing critical insights for biopharmaceuticals.
- 31
- Company
- San Juan, PR, USUnited States

PDS offers ProteinMentorTM, a high-tech analytical platform providing critical insights for biopharmaceuticals.
pdsbio.comCrawled Oct 15, 2026
Protein Dynamic Solutions shares its latest happenings and past milestones.
The company says its Boston site is located for access to its client base and industry thought leaders.
Protein Dynamic Solutions Inc. was founded by biopharmaceutical scientists to fulfill a need for improved Critical Quality Attribute (CQA) analysis.
The company offers platform demonstrations and discussions about application needs.
PDS' technology allows biopharmaceutical companies to evaluate CQAs essential to drug candidate selection, formulation and release testing.
Protein Dynamic Solutions (PDS) states that its Privacy Policy describes its privacy practices and covers personal information collected through its website.
Protein Dynamic Solutions introduces **ProteinMentor**, a multi-attribute platform technology designed for the biopharma industry. The platform was unveiled at the **PEGS Boston Summit**, targeting applications in protein analysis and drug development. It integrates advanced computational tools to streamline biopharmaceutical research workflows.
May 2024PR NewswireNews article
Business Insider ranks the highest-valued venture-backed startups across all 50 U.S. states, Washington D.C., and Puerto Rico. The list highlights lesser-known companies outside California, showcasing regional innovation hubs. Uber and WeWork appear among the top entries, reflecting their significant valuations. OfferUp is also included, emphasizing the diversity of industries represented.
Jun 2018Business InsiderNews article
Protein Dynamic Solutions LLC (PDS) opens a new headquarters and research facility in Wakefield, Massachusetts. The company develops platforms for assessing biopharmaceutical critical quality attributes (CQAs) and biosimilar evaluation. This expansion consolidates its operations in the state.
Jun 2018BioPharma DiveNews article